Emprendimiento NORNA

La creación de Norna Ltda., motivada por la expansión mundial de la idea del cuidado por el planeta, junto con el avance económico de Colombia se implanta como la base de un movimiento social y cultural que pretende expandirse por el país. Para la empresa, el objetivo principal es realzar el valor de la conservación del medio ambiente, a través de un bien tangible, para evitar la perpetuación de la sostenibilidad ecológica e inclusión social como una idea impalpable. Para confrontar el Statu Quo de la moda rápida que regularmente se encuentra acompañada por condiciones laborales lamentables, Norna ltda., confecciona y distribuye chaquetas a base de algodón orgánico a través de su página virtual en Colombia.

Primary Joint Arthroplasty Surgery: Is the Risk of Major Bleeding Higher in Elderly Patients? A Retrospective Cohort Study

Increased risk of bleeding after major orthopedic surgery (MOS) has been widely documented in general population. However, this complication has not been studied in elderly patients. The purpose of this study is to determine whether the risk of major bleeding after MOS is higher in elderly patients, compared with those operated at a younger age. Methods: This retrospective cohort study included total hip and total knee arthroplasty patients operated during 5 consecutive years. The main outcome was the occurrence of major bleeding. Patients with other causes of bleeding were excluded. Relative risks (RRs) and confidence intervals (CIs) were calculated, anda multivariate analysis was performed. Results: A total of 1048 patients were included, 56% of patients were hip arthroplasties. At the time of surgery, 553 (53%) patients were older than 70 years. Patients aged >70 years showed an increased risk of major bleeding (RR: 2.42 [95% CI: 1.54-3.81]). For hip arthroplasty, the RR of bleeding was 2.61 (95%CI: 1.50-4.53) and 2.25 (95% CI: 1.03-4.94) for knee arthroplasty. After multivariate analysis, age was found to be independently associated with higher risk of major bleeding. Conclusion: According to European Medicines Agency criteria, patients aged 70 years are at a higher risk of major bleeding after MOS, result of a higher frequency of blood transfusions in this group of patients. Standardized protocols for blood transfusion in these patients are still required.